Evidence map›Paper›PMID 39080385›Full record

ArticleScientific reports2024

Suppression of gp130 attenuated insulin-mediated signaling and glucose uptake in skeletal muscle cells.

Koji Sato

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Koji SatoGraduate School of Human Development and Environment, Kobe University, 3-11 Tsurukabuto, Nada-ku, Kobe, Hyogo, 657-8501, Japan. sato712@people.kobe-u.ac.jp.ORCID 0000-0003-3293-6420

Funding

Japan Society for the Promotion of Science 21K11466
6 · The paper itself

Abstract

The aim of the present study was to investigate the effects of Oncostatin M receptor (OSMR) subunit gp130 knockdown on insulin-stimulated glucose metabolism-related signaling pathways and glucose uptake in skeletal muscle cells. siRNA-mediated gp130 knockdown was conducted in C2C12 muscle cells, and insulin was added and incubated for 1 h. The cells were cultivated to analyze the mRNA levels of gp130, phosphorylation of STAT3, and glucose metabolism-regulated signaling pathways, and OSM levels in the culture medium were analyzed. The phosphorylation of STAT 3 was significantly decreased in gp130

Indexed as

Cytokine Receptor gp130GlucoseInsulinSignal TransductionSTAT3 Transcription FactorAnimalsCell LineGene Knockdown TechniquesMiceMuscle Fibers, SkeletalMuscle, SkeletalPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktCytokine Receptor gp130GlucoseInsulinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSTAT3 Transcription FactorGlucose metabolismInsulin actionOncostatin MSkeletal muscle

Identifiers

PMID39080385
PMCPMC11289081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.